ABG Innovation Capital Partners III GP as of March 31, 2021
Portfolio Holdings for ABG Innovation Capital Partners III GP
ABG Innovation Capital Partners III GP holds 7 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Atea Pharmaceuticals | 80.1 | $163M | 2.6M | 61.75 | |
| Pulmonx Corp (LUNG) | 18.7 | $38M | 833k | 45.74 | |
| Genocea Biosciences Com New (GNCAQ) | 0.5 | $1.0M | 375k | 2.71 | |
| Synlogic | 0.4 | $737k | 206k | 3.58 | |
| Aerpio Pharmaceuticals | 0.3 | $516k | 400k | 1.29 | |
| Nabriva Therapeutics SHS | 0.0 | $76k | 46k | 1.66 | |
| Idera Pharmaceuticals Com Par | 0.0 | $73k | 56k | 1.30 |
